SCHEMBL5284424

SCHEMBL5284424

CC(C)=N/N=c1\sc(C)c(-c2ccccc2)n1Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 4/20 0.38
TSHR P16473 1/20 0.38
PDE6D O43924 1/20 0.37
ALDH2 P05091 1/20 0.37
ALDH3A1 P30838 1/20 0.37
CFTR P13569 1/20 0.36
TP53 P04637 2/20 0.35
KDM4E B2RXH2 3/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TNF P01375 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283806 1.00 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2RAB9ANPC1CYP1A2
SCHEMBL5282968 0.85 TSHR (0.44) ALDH1A1SMN1; SMN2LMNATSHRCFTR
SCHEMBL5282965 0.85 TSHR (0.44) ALDH1A1SMN1; SMN2LMNATSHRCFTR
SCHEMBL5281141 0.79 NPC1 (0.51) ALDH1A1SMN1; SMN2RAB9ANPC1CYP1A2
SCHEMBL5281146 0.79 NPC1 (0.51) ALDH1A1SMN1; SMN2RAB9ANPC1CYP1A2
SCHEMBL5283318 0.77 KMT2A (0.40) ALDH1A1SMN1; SMN2RAB9ANPC1CYP1A2
SCHEMBL5279506 0.77 KMT2A (0.40) ALDH1A1SMN1; SMN2RAB9ANPC1CYP1A2
SCHEMBL5285829 0.76 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2RAB9ANPC1CYP1A2
SCHEMBL5285831 0.76 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2RAB9ANPC1CYP1A2
SCHEMBL5278251 0.75 SMN1; SMN2 (0.44) ALDH1A1SMN1; SMN2RAB9ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT ALDH1A1 454/4885SMN1; SMN2 3523/4885RAB9A 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.